Gilead Sciences (GILD) Earnings Date, Estimates & Call Transcripts → What is Medicare Supplement Insurance? (From Tranzact) (Ad) Free GILD Stock Alerts $67.03 +0.08 (+0.12%) (As of 04/23/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateApr. 25After Market ClosesConfirmedActual EPS (Feb. 6) $1.72 Missed By -$0.04 Consensus EPS (Feb. 6) $1.76 Read Call TranscriptListen to Call Get Gilead Sciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for GILD and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueGILD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GILD Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Whats On FinancePutin and other countries have a planDid you catch that bombshell Tucker Carlson interview with Vladimir Putin? It’s not about if you like Tucker or think Putin is the devil or whatever. It's all about the fact that the US dollar might be taking a back seat... and soon. Click to kickstart your journey to survive in the new economy Gilead Sciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20244$1.38$1.97$1.64 Q2 20244$1.54$1.98$1.76 Q3 20244$1.85$2.10$1.96 Q4 20244$1.84$1.98$1.89 FY 202416$6.61$8.03$7.24 Q1 20251$1.54$1.54$1.54 Q2 20251$1.59$1.59$1.59 Q3 20251$2.14$2.14$2.14 Q4 20251$1.96$1.96$1.96 FY 20254$7.23$7.23 $7.23GILD Earnings Date and InformationGilead Sciences last released its earnings data on February 6th, 2024. The biopharmaceutical company reported $1.72 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.76 by $0.04. The company had revenue of $7.12 billion for the quarter, compared to the consensus estimate of $7.10 billion. Its quarterly revenue was down 3.7% compared to the same quarter last year. Gilead Sciences has generated $4.50 earnings per share over the last year ($4.50 diluted earnings per share) and currently has a price-to-earnings ratio of 14.9. Earnings for Gilead Sciences are expected to grow by 11.76% in the coming year, from $6.55 to $7.32 per share. Gilead Sciences has confirmed that its next quarterly earnings report will be published on Thursday, April 25th, 2024. Gilead Sciences will be holding an earnings conference call on Thursday, April 25th at 4:30 PM Eastern. Interested parties can register for or listen to the call.. Read More Gilead Sciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 4/25/2024Confirmed)------- 2/6/2024Q4 2023$1.76$1.72($0.04)$2.30$7.10 billion$7.12 billion 11/7/2023Q3 2023$1.91$2.29+$0.38$2.85$6.81 billion$7.05 billion 8/3/2023Q2 2023$1.64$1.34($0.30)$1.85$6.45 billion$6.60 billion 4/27/2023Q1 2023$1.63$1.37($0.26)$1.94$6.33 billion$6.35 billion 2/2/2023Q4 2022$1.50$1.67+$0.17$2.04$6.63 billion$7.39 billion 10/27/2022Q3 2022$1.44$1.90+$0.46$2.38$6.12 billion$7.04 billion Get the Latest News and Ratings for GILD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gilead Sciences and its competitors with MarketBeat's FREE daily newsletter. 8/2/2022Q2 2022$1.51$1.58+$0.07$2.25$5.88 billion$6.26 billion4/28/2022Q1 2022$1.77$2.12+$0.35$4.22$6.28 billion$6.59 billion 2/1/2022Q4 2021$1.53$0.69($0.84)$1.08$6.64 billion$7.24 billion 10/28/2021Q3 2021$1.72$2.65+$0.93$3.25$6.31 billion$7.42 billion 7/29/2021Q2 2021$1.76$1.87+$0.11$2.53$6.15 billion$6.22 billion 4/29/2021Q1 2021$2.06$2.08+$0.02$2.79$6.78 billion$6.42 billion Gilead Sciences Earnings - Frequently Asked Questions When is Gilead Sciences's earnings date? Gilead Sciences has confirmed that its next quarterly earnings data will be published on Thursday, April 25th, 2024. Learn more on GILD's earnings history. Did Gilead Sciences beat their earnings estimates last quarter? In the previous quarter, Gilead Sciences (NASDAQ:GILD) missed the analysts' consensus estimate of $1.76 by $0.04 with a reported earnings per share (EPS) of $1.72. Learn more on analysts' earnings estimate vs. GILD's actual earnings. How can I listen to Gilead Sciences's earnings conference call? The conference call for Gilead Sciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Gilead Sciences's conference call transcript? The conference call transcript for Gilead Sciences's latest earnings report can be read online. Read Transcript How much revenue does Gilead Sciences generate each year? Gilead Sciences (NASDAQ:GILD) has a recorded annual revenue of $27.12 billion. How much profit does Gilead Sciences generate each year? Gilead Sciences (NASDAQ:GILD) has a recorded net income of $5.67 billion. GILD has generated $4.50 earnings per share over the last four quarters. What is Gilead Sciences's price-to-earnings ratio? Gilead Sciences (NASDAQ:GILD) has a trailing price-to-earnings ratio of 14.90 and a forward price-to-earnings ratio of 10.23. The price/earnings-to-growth ratio is 0.92. What is Gilead Sciences's EPS forecast for next year? Gilead Sciences's earnings are expected to grow from $6.55 per share to $7.32 per share in the next year, which is a 11.76% increase. More Earnings Resources from MarketBeat Related Companies: SGEN Earnings Date BIIB Earnings Date AMGN Earnings Date MRNA Earnings Date ARGX Earnings Date HCA Earnings Date GSK Earnings Date ZTS Earnings Date BMY Earnings Date REGN Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NASDAQ:GILD) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
